By Mari Hansen 
A robotic arm moves slowly and precisely over a growing structure the size of a golf ball in a bioengineering lab on the Stanford campus. At this point, it appears to be nothing more than a reddish, gelatinous mass sitting in a controlled environment, but surgeons and pediatric cardiologists have been waiting decades for what it is or is becoming.
The arm is creating the structure of a human heart from the inside out by depositing living cells layer by incredibly thin layer. No donor is involved. There is no waiting list. No immune system is surreptitiously planning rejection. Just a bioprinter, a carefully designed stem cell paste, and the start of something that, five years ago, most medical professionals would not have thought was this close.
| Stanford 3D Bioprinted Heart Research — Key Facts & Profile | |
|---|---|
| Institution | Stanford University — Schools of Engineering and Medicine; BASE Initiative |
| Lead Researchers | Mark Skylar-Scott (Asst. Prof. Bioengineering) & Alison Marsden (Prof. Pediatrics & Bioengineering) |
| Published Research | Science journal, June 12, 2025 — new vascular tree design & bioprinting platform |
| Key Breakthrough | Algorithm generates full cardiac vascular tree model (~1 million blood vessels) in 5 hours — 200× faster than prior methods |
| Printing Method | 3D bioprinter using living cells (organoids from stem cell paste); layer-by-layer construction mimicking organ architecture |
| Vascular Density Achieved | Cells within 100–150 microns of nearest blood vessel; ~2,500+ capillaries per mm³ in heart tissue |
| Target Beneficiaries | 100,000+ people on U.S. organ transplant lists; children with congenital heart disease |
| Current Limitation | Printed channels are not yet fully physiological blood vessels; lack muscle cells, endothelial cells, fibroblasts |
| Open Source Tool | SimVascular — vascular design software made freely available to researchers worldwide |
| Reference / Source | Stanford Report — Designing Blood Vessels for 3D Printed Hearts (stanford.edu) |
For years, Mark Skylar-Scott, an assistant professor of bioengineering at Stanford, has been working toward this goal. The expression on his face in lab photos—focused, cautious, refusing to oversell—tells you something about where they truly are versus where the headlines want to put them. The June 2025 publication of the study in the journal Science represents significant advancements.
Considerable advancement, in fact. Together with professor Alison Marsden of cardiovascular bioengineering, his team unveiled a new platform for creating and 3D printing the branching network of blood vessels that carry nutrients and oxygen to every cell, down to the tiniest capillary, that any printed organ would require to survive. For years, this has been the main unresolved issue with bioprinted organs. Cells can be grown. Structures are printable. Once the structure is thicker than a few millimeters, it becomes difficult to keep those cells alive because they starve in the absence of blood.
It’s important to comprehend the numbers underlying the breakthrough. Cells in the majority of tissues must remain within about a hair’s width of a blood vessel in order to survive. The need is even more stringent in the heart, which requires more oxygen than practically any other tissue; a single cubic millimeter of cardiac muscle may have over 2,500 capillaries.
It used to take months to create a computer model of the vascular tree required to supply a complete human heart, with one million individual blood vessels mapped at that density using earlier algorithms. A new one created by Marsden’s team completes the task in five hours. Through their SimVascular open-source project, they have made the software freely available. This is the kind of subtle, confident gesture that serious researchers make when they think their work is reliable enough to be shared.
Physical printing has already replaced computer modeling in the lab. Using living cells suspended in a biomaterial instead of plastic or resin, a bioprinter created a thick ring of tissue that was filled with human embryonic kidney cells and had a network of 25 channels running through it. The cells were kept alive by nutrient-rich fluid that was pumped through those channels. A more intricate model with 500 branches was also printed by the team. Not a million. Not just yet. However, the direction is obvious, and the rate of advancement is actually quicker than most bioengineers would have thought even three years ago.
The individuals who stand to gain the most from this work are not hypothetical. In the United States, there are currently over 100,000 people waiting for organ transplants, and some of them won’t make it. Children born with congenital heart defects—malformations that modern surgery can manage but rarely cure—are among the most devastating; their families must deal with limitations, follow-up procedures, and uncertainty for the rest of their lives. Skylar-Scott has expressed this clearly.
One of the most prevalent congenital birth defects in the nation is pediatric heart disease. Lives can be prolonged by surgery. It is unable to replace damaged tissue with something that performs the same functions as healthy tissue. Theoretically, a printed organ made from a patient’s own stem cells can simultaneously address the rejection and shortage issues. Donor matching is not necessary. Never take immunosuppressive drugs. simply artificial tissue that the body is able to identify as its own.
The difference between “major breakthrough” and “ready for transplant” in this field has burned people before, so it’s important to be clear about where the research truly stands. As of yet, Skylar-Scott and Marsden’s team’s printed vascular channels are not actual blood vessels.
They lack the smooth muscle, endothelial cells, and structural proteins necessary for a real vessel to function over time. The fact that the researchers themselves state this clearly is actually comforting because it implies that they are carefully constructing the device rather than acting for cameras. Dominic Rütsche, one of the team’s postdoctoral scholars, stated, “We’re working on that,” with the kind of understatement that comes from doing actual science rather than making an announcement.
It’s not a single paper that stands out when you watch this work develop over the past few years, but rather the cumulative weight of the advancements—the algorithm operating 200 times faster, the printed tissue surviving, and the pipeline becoming cleaner and more dependable with every published study. It has always been theoretically feasible to print a human heart from a patient’s own cells. Whether the engineering could arrive quickly enough to be significant was always the question. That question feels truly open for the first time in a long time.